🇨🇦 Rifampin-combination therapy in Canada

Rifampin-combination therapy (Rifampin-combination therapy) regulatory status in Canada.

Marketing authorisation

Rifampin-combination therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rifampin-combination therapy approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Rifampin-combination therapy in Canada?

Oslo University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.